...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

"dont seem to be reaching in & trying to grab 100's of thousands at this level?? "

"ZHCLF" is in limited supply.

 

Koo

 

Share
New Message
Please login to post a reply